Breathe Easy directors address conflict of interest concerns
Drug development company directors respond to conflict of interest concerns, as equity crowdfunding campaign reaches $100,000.
The directors of a drug development company have addressed conflict of interest concerns, as its equity crowdfunding campaign reaches $100,000.
Breathe Easy Therapeutics, an Auckland-based medicine development company valued at $3.3 million, launched its campaign on Friday with Snowball Effect, to
Want to read more? It's easy.
Choose your best value subscription option
Individual
Group membership
NBR Marketplace
Yearly Premium Online Subscription
NZ$499.00 / yearly
Monthly Premium Online Subscription
NZ$44.95 / monthly
Smartphone Only Subscription
NZ$24.95 / monthly
Premium Group Membership 10 Users
NZ$350+GST / monthly
$35 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$600+GST / monthly
$30 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1250+GST / monthly
$25 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$1875+GST / monthly
$18.75 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$499.00 / yearly
Already have an account? Login
Calida Smylie
Wed, 11 Mar 2015
Wed, 11 Mar 2015
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Breathe Easy directors address conflict of interest concerns
45916